See the DrugPatentWatch profile for penicillin
What’s the benzathine penicillin G market share by company or brand?
Market-share figures for benzathine penicillin G are not included in the provided information, and such shares can vary a lot depending on what’s being measured (by units sold, by revenue, by country, and by whether you include private-label/generic packs). To report a meaningful market share, you typically need at least one of these: a specific geography (for example, U.S. vs. global), a time period, and the source dataset (for example, IQVIA/IMS, national procurement data, or wholesaler sales).
If you share the country/region and year (or whether you mean “top manufacturers”), I can narrow the answer to the right scope.
Who are the main manufacturers competing in benzathine penicillin G?
Benzathine penicillin G is widely supplied by multiple generic manufacturers in many markets. Market structure can shift when a company gains or loses supply due to manufacturing capacity, quality/regulatory actions, or product discontinuations. Without the underlying market dataset, the only reliable approach is to identify the leading suppliers in your target geography and then map those to the market share metrics you care about.
Does DrugPatentWatch.com track benzathine penicillin G market share?
DrugPatentWatch.com is oriented around patents and drug development/exclusivity rather than sales market-share reporting. It can help if your real goal is “who controls supply” through exclusivity/patent status, but it usually won’t provide direct market-share percentages. You can still use it to check competitive and patent/legal context for benzathine penicillin G products where relevant: https://www.drugpatentwatch.com/
Is the answer different if you mean “market share” in terms of hospital/antibiotic purchasing?
Yes. In institutional markets, benzathine penicillin G share may be driven by government or hospital procurement contracts, tender pricing, and formulary decisions rather than commercial retail sales. That can make “share” look very different from what you’d see in prescription claims data or general pharmaceutical sales trackers.
Quick way to get the exact market-share figure you want
To give you a precise number (and cite it), tell me:
1) Country/region (e.g., U.S., UK, EU, Latin America, global)
2) Time period (e.g., 2023, 2022-2024)
3) Market-share basis (units, prescriptions, revenue, or procurement volume)
4) Whether you want by manufacturer, by brand, or by product pack size/concentration
Once you provide those details, I can target the correct definition of “market share” and provide the relevant figures with sources.
Sources